The BIOFIRE^® SPOTFIRE^® Respiratory Solution

The SPOTFIRE System is the latest advancement in molecular infectious disease diagnostics. It is designed to run the SPOTFIRE Respiratory Panels.

• Requires minimal benchtop space and can be scaled vertically, up to four modules, enabling customizable throughput
• Easy to use with an intuitive system interface and streamlined workflow
• Can be used by any healthcare professional in any healthcare setting
• Seamlessly connects with point-of-care data management systems and other compatible systems and software

The SPOTFIRE R/ST Panel enables testing for both respiratory or sore throat pathogens on the same panel, providing a flexible respiratory solution to meet the unique needs of your care setting.  FDA CLEARED | CLIA WAIVED

*Product not yet available for sale.

The SPOTFIRE R/ST Panel Mini tests for the 5 most probable viruses or bacteria that cause respiratory and sore throat symptoms, including influenza, rhinovirus, respiratory syncytial virus SARS-CoV-2, and streptococcal pharyngitis.

**Under FDA review. Intending to seek CLIA waiver. Subject to change. Product not available for sale.

The SPOTFIRE R Panel brings diagnostic power to clinicians via a lab-grade, PCR-based expanded syndromic approach. In other words, the SPOTFIRE R Panel combines symptom-driven testing for a broad grouping of probable respiratory pathogens into one rapid test that aids in the diagnosis of patients experiencing signs or symptoms of respiratory tract infections, maximizing the change of getting an actionable answer in a clinically relevant timeframe.

FDA CLEARED | CLIA WAIVED

The SPOTFIRE R Panel Mini brings the power of targeted syndromic testing via lab-quality PCR results to the front line. It tests for the 5 most probable viruses that cause respiratory tract infections, including influenza, rhinovirus, respiratory syncytial virus, and SARS-CoV-2. This panel runs on the easy-to-use SPOTFIRE System, which provides results in about 15 min.

FDA CLEARED | CLIA WAIVED

Inform Clinical Decisions

• High sensitivity, specificity, and reliability provides results clinicians can trust
• Contrary to tests that only detect the flu, SARS-COV-2, and/or RSV, a syndromic panel provides a fuller picture that may help inform patient management decisions

Optimize Operations

• The simplified workflow and quick turnaround time enable rapid and accurate answers during the patient visit, while reducing the need for callbacks or expensive and slow send-out testing
• This easy-to-use solution enables users of all skill levels to prepare and run samples

Optimize Antimicrobial Stewardship

• Receiving comprehensive results in a clinically actionable timeframe may inform diagnoses while optimizing care and antimicrobial stewardship

Improve Patient Satisfaction

• Using the right test, the first time to detect multiple pathogens may result in reduced follow-up appointments, swabbing, and testing, which could improve patient comfort, experience, and convenience